Exogenous bacterial DnaK increases protein kinases activity in human cancer cell lines

Francesca Benedetti1, Sabrina Curreli2, Robert C Gallo2

  • 1Institute of Human Virology and Global Virus Network Center, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.

Abstract

Insights

Mycoplasma DnaK protein disrupts cancer cell signaling by altering kinase activity, potentially driving cancer progression. This finding reveals a new mechanism for how the human microbiota influences cancer development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Microbiology

Background:

  • Kinases play a critical role in cancer cell signaling, regulating pathways involved in carcinogenesis and progression.
  • The human microbiota, including Mycoplasmas, is increasingly recognized for its influence on cancer development and treatment outcomes.
  • Mycoplasmas and their proteins are present in the tumor microenvironment and linked to cellular transformation.

Purpose of the Study:

  • To investigate the impact of Mycoplasma DnaK on kinase activity in various cancer cell lines.
  • To elucidate the role of bacterial proteins from the human microbiota in cancer signaling.

Main Methods:

  • Treatment of four eukaryotic cancer cell lines (lung, prostate, colon adenocarcinoma, neuroblastoma) with exogenous Mycoplasma DnaK.
  • Measurement of kinase and specific substrate phosphorylation at 20 and 60 minutes post-treatment.
  • Kinome analysis to assess global kinase activity changes.

Main Results:

  • Mycoplasma DnaK significantly dysregulates the activity of specific kinases and their substrates.
  • These affected kinases and substrates are known to be involved in carcinogenesis and cancer progression.
  • The study identified a novel mechanism of kinase dysregulation mediated by bacterial proteins.

Conclusions:

  • Mycoplasma DnaK alters host cell phosphorylation, contributing to cancer progression.
  • Bacterial components within the tumor microenvironment can deregulate critical cellular signaling pathways.
  • This research highlights a new pathway through which the human microbiota impacts cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.6K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.1K